Role of the I416L Variant of Complement Factor I in Thrombotic Microangiopathy Among Patients of African Ancestry.
作者信息
Nobile Giulio, Doreille Alice, Raymond Laure, Robert Thomas, Dancer Marine, Mesnard Laurent, Rafat Cédric
机构信息
Service de Soins Intensifs Néphrologique et Rein Aigu, hôpital Tenon, Assistance Publique - Hôpitaux de Paris, Paris, France.
Faculté de médecine, Sorbonne Université, Paris, France.
出版信息
Kidney Int Rep. 2023 Aug 11;8(10):2136-2140. doi: 10.1016/j.ekir.2023.07.027. eCollection 2023 Oct.
Abstract
摘要
相似文献
1
Role of the I416L Variant of Complement Factor I in Thrombotic Microangiopathy Among Patients of African Ancestry.补体因子I的I416L变体在非洲裔患者血栓性微血管病中的作用。
Kidney Int Rep. 2023 Aug 11;8(10):2136-2140. doi: 10.1016/j.ekir.2023.07.027. eCollection 2023 Oct.
2
The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report.依库珠单抗在犬咬二氧化碳嗜纤维菌相关血栓性微血管病中的应用：一例报告
BMC Infect Dis. 2021 Feb 1;21(1):137. doi: 10.1186/s12879-021-05789-2.
3
Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.血栓性微血管病伴狼疮性肾炎时的替代补体途径激活。
Clin Rheumatol. 2021 Jun;40(6):2233-2242. doi: 10.1007/s10067-020-05499-1. Epub 2020 Nov 10.
4
Thrombotic microangiopathy due to acquired complement factor I deficiency in a male receiving interferon-beta treatment for multiple sclerosis.一名接受干扰素-β治疗多发性硬化症的男性因获得性补体因子I缺乏症导致血栓性微血管病。
Br J Clin Pharmacol. 2023 May;89(5):1682-1685. doi: 10.1111/bcp.15631. Epub 2022 Dec 23.
5
Complement Factor H Gene Variant in a Patient with Thrombotic Microangiopathy on a Mixed Clinical Background.一名具有混合临床背景的血栓性微血管病患者的补体因子H基因变异体
Case Rep Nephrol. 2021 Oct 25;2021:2519918. doi: 10.1155/2021/2519918. eCollection 2021.
6
Characteristics and management of thrombotic microangiopathy in kidney transplantation.肾移植中血栓性微血管病的特征与管理
Korean J Transplant. 2023 Mar 31;37(1):11-18. doi: 10.4285/kjt.23.0011.
7
Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy.患有补体基因变异介导的血栓性微血管病的肾移植受者的妊娠情况
Clin Kidney J. 2020 Aug 20;14(4):1255-1260. doi: 10.1093/ckj/sfaa113. eCollection 2021 Apr.
8
IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome.非典型溶血性尿毒症综合征中针对补体因子H的IgM自身抗体
J Am Soc Nephrol. 2021 May 3;32(5):1227-1235. doi: 10.1681/ASN.2020081224. Epub 2021 Mar 12.
9
Complement activation in diseases presenting with thrombotic microangiopathy.补体激活与血栓性微血管病。
Eur J Intern Med. 2013 Sep;24(6):496-502. doi: 10.1016/j.ejim.2013.05.009. Epub 2013 Jun 4.
10
What complements complement in transplant-associated thrombotic microangiopathy?移植相关性血栓性微血管病中补体的互补作用是什么？
Br J Haematol. 2022 Nov;199(4):477-479. doi: 10.1111/bjh.18402. Epub 2022 Aug 9.
引用本文的文献
1
Response to "Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition": Still a Long Way to Go.对《产后出血相关血栓性微血管病的特征及短期补体抑制的作用》的回应：仍有很长的路要走。
Kidney Int Rep. 2024 May 4;9(7):2306. doi: 10.1016/j.ekir.2024.04.063. eCollection 2024 Jul.
2
Rare Variants in Complement Genes May Not Be That Rare After All.补体基因中的罕见变异可能终究并非那么罕见。
Kidney Int Rep. 2023 Aug 23;8(10):1911-1913. doi: 10.1016/j.ekir.2023.08.020. eCollection 2023 Oct.
本文引用的文献
1
How I treat thrombotic microangiopathy in the era of rapid genomics.在快速基因组学时代，我如何治疗血栓性微血管病。
Blood. 2023 Jan 12;141(2):147-155. doi: 10.1182/blood.2022015583.
2
The Syndromes of Thrombotic Microangiopathy: A Critical Appraisal on Complement Dysregulation.血栓性微血管病综合征：对补体失调的批判性评估
J Clin Med. 2021 Jul 8;10(14):3034. doi: 10.3390/jcm10143034.
3
Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics.血栓性微血管病在 aHUS 及其他疾病中的作用：补体遗传学的临床线索。
Nat Rev Nephrol. 2021 Aug;17(8):543-553. doi: 10.1038/s41581-021-00424-4. Epub 2021 May 5.
4
Hypertensive nephropathy: a major roadblock hindering the advance of precision nephrology.高血压肾病：阻碍精准肾脏病学发展的主要障碍。
Clin Kidney J. 2020 Sep 2;13(4):504-509. doi: 10.1093/ckj/sfaa162. eCollection 2020 Aug.
5
Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome.高血压危象和罕见补体变异对非典型溶血尿毒综合征的表现和结局的影响。
Haematologica. 2019 Dec;104(12):2501-2511. doi: 10.3324/haematol.2019.216903. Epub 2019 Mar 19.
6
Hypertensive Crisis and Refractory Hypertension Caused by Atypical Hemolytic Uremic Syndrome and Effect of Eculizumab.非典型溶血性尿毒症综合征所致高血压危象和难治性高血压以及依库珠单抗的疗效
Acta Cardiol Sin. 2018 Sep;34(5):446-449. doi: 10.6515/ACS.201809_34(5).20180326D.
7
Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities.高血压相关性血栓性微血管病患者可能会出现补体异常。
Kidney Int. 2017 Jun;91(6):1420-1425. doi: 10.1016/j.kint.2016.12.009. Epub 2017 Feb 7.
8
Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome.补体成分的突变影响因子 I 相关非典型溶血尿毒综合征的结局。
Kidney Int. 2010 Feb;77(4):339-49. doi: 10.1038/ki.2009.472. Epub 2009 Dec 16.
Zotero 插件